Mariana Mihalusova
Vice President at Venrock
Mariana Mihalusova
Vice President at Venrock
San Francisco Bay Area
Overview
Work Experience
Board Observer
2024 - Current
Board Observer
2023
Board Member
2022
Board Observer
2021
Board Observer
2020
Vice President
2020
Executive Director, Global Project Leadership, Research & Early Development
2017 - 2020
Celgene was acquired by Bristol-Myers Squibb Company in Nov 2019. Led drug development efforts for 15 compounds (small molecules, biologics, engineered cell therapies) in hematology, oncology, inflammation/immunology, and neurodegenerative diseases. Responsible for the formulation and execution of global integrated development strategies, including scientific rationale, clinical development, budget, regulatory, and technical strategies. Managed large, cross-functional teams comprised of discovery, clinical, clinical operations, translational, regulatory, IP, commercial, CMC, toxicology, DMPK, clinical pharmacology, drug safety, medical affairs, and market access.
Senior Director, Global Project Leadership, Research & Early Development
2015 - 2017
Director, Global Project Leadership, Research & Early Development
2015 - 2015
Associate Director, Global Project Leadership
2014 - 2015
Sr. Manager, Global Project Leadership
2012 - 2014
Graduate Research Assistant / Teaching Fellow
2004 - 2010
Research areas: single-molecule/nanoscale imaging and analysis, telomerase structure and function Teaching Fellow: Molecular Pathophysiology and Pharmacology of Human Disease, Molecular Genetics of Neural Development and Behavior, and Molecular Biology.